Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mollman, J. E.
Right arrow Articles by McCluskey, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mollman, J. E.
Right arrow Articles by McCluskey, L. F.
NEUROLOGY 1988;38:488
© 1988 American Academy of Neurology

Unusual presentation of cis-platinum Neuropathy

Joan E. Mollman, MD, W. Michael Hogan, MD, Donna J. Glover, MD and Leo F. McCluskey, MD

From the Departments of Neurology (Drs. Mollman and McCluskey), Obstetrics and Gynecology (Dr. Hogan), and Medicine (Dr. Glover), Division of Hematology-Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA.

Symptoms and signs of cis-diamminedichloroplatinum II (DDP) neuropathy usually develop during treatment and stabilize or improve when DDP is stopped. We report three patients whose symptoms began 3 to 8 weeks after the last dose of DDP and progressed over 1 or 2 months to moderate-marked disability. The clinical picture in each was consistent with DDP neuropathy, and no other cause could be identified. Two of the patients improved over 8 and 27 months to become asymptomatic; the other died 2 months after presentation. It is important to recognize that DDP neuropathy can present after treatment has been discontinued since the clinical picture mimics the para-neoplastic dorsal root ganglionitis, which has a different prognosis.

Address correspondence and reprint requests to Dr. Mollman, Department of Neurology, University of Pennsylvania, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104.

Dr. Mollman is the recipient of NINCDS Teacher-Investigator Award #NS00563.

Presented in part at the thirty-seventh annual meeting of the American Academy of Neurology, Dallas, TX, April 1985.

Received February 4, 1987. Accepted for publication in final form June 3, 1987.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
O. Heinzlef, J.-P. Lotz, and E. Roullet
Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapy
J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 667 - 669.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.